Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers
Clinical trial NCT02696616 · COMPLETED
Trial details
- NCT number
- NCT02696616
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-16
- Primary completion
- 2019-02-14
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.